Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Harris

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|November 19, 2013
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid usersStephen C Harris, Peter J Perrino, Ira Smith, et al.
Clinical Pharmacology in Drug Development|March 13, 2024
Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-Ascending Doses of Sunobinop in Healthy ParticipantsAlessandra Cipriano, Ram P Kapil, Mingyan Zhou, et al.
Drugs & Aging|September 24, 2014
Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjectsDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
JAMA|July 6, 2006
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trialPaul B Watkins, Neil Kaplowitz, John T Slattery, et al.
Drug Discovery Today|June 21, 2016
FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory scienceHong Fang, Stephen C Harris, Zhichao Liu, et al.
Human Genomics|December 19, 2012
SNPTrack™ : an integrated bioinformatics system for genetic association studiesJoshua Xu, Reagan Kelly, Guangxu Zhou, et al.
Journal of Clinical Psychopharmacology|April 3, 2026
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Interactions Between Alcohol and Sunobinop in Healthy ParticipantsStephen C Harris, Manjunath S Shet, Alessandra Cipriano, et al.
Clinical Therapeutics|April 2, 2013
Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adultsDavid J Greenblatt, Jerold S Harmatz, Thomas Roth, et al.
Journal of Pain and Symptom Management|October 3, 2012
Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levelsRam P Kapil, Alessandra Cipriano, Kristen Friedman, et al.
Journal of Clinical Pharmacology|November 9, 2013
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administrationDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|November 19, 2013
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid usersStephen C Harris, Peter J Perrino, Ira Smith, et al.
Clinical Pharmacology in Drug Development|March 13, 2024
Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-Ascending Doses of Sunobinop in Healthy ParticipantsAlessandra Cipriano, Ram P Kapil, Mingyan Zhou, et al.
Drugs & Aging|September 24, 2014
Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjectsDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
JAMA|July 6, 2006
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trialPaul B Watkins, Neil Kaplowitz, John T Slattery, et al.
Drug Discovery Today|June 21, 2016
FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory scienceHong Fang, Stephen C Harris, Zhichao Liu, et al.
Human Genomics|December 19, 2012
SNPTrack™ : an integrated bioinformatics system for genetic association studiesJoshua Xu, Reagan Kelly, Guangxu Zhou, et al.
Journal of Clinical Psychopharmacology|April 3, 2026
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Interactions Between Alcohol and Sunobinop in Healthy ParticipantsStephen C Harris, Manjunath S Shet, Alessandra Cipriano, et al.
Clinical Therapeutics|April 2, 2013
Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adultsDavid J Greenblatt, Jerold S Harmatz, Thomas Roth, et al.
Journal of Pain and Symptom Management|October 3, 2012
Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levelsRam P Kapil, Alessandra Cipriano, Kristen Friedman, et al.
Journal of Clinical Pharmacology|November 9, 2013
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administrationDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
Pageof 4